Microbiome, genetic and advanced diagnostic testing built around meaningful clinical and lifestyle decisions.
The portfolio is structured into four main areas: genetic testing, microbiome diagnostics, dry blood spot home testing and point-of-care clinical solutions.
Advanced genetic testing for personalized healthcare, prevention and treatment optimization, including pharmacogenetics and carrier screening.
Comprehensive gut and oral microbiome profiling from home collection kits, focused on balance, protective species and clinically relevant risk markers.
Clinical-grade biomarker testing from a single fingerprick sample at home for stress, metabolism, immunity and cellular energy.
Laboratory-grade diagnostics at the place of care, designed for faster clinical decisions and better patient understanding during one visit.
Overview of key diagnostic services based on the company’s professional focus and public offer.
Pharmacogenomics, carrier screening and targeted personalized diagnostics for specific clinical situations.
Omega 3/6 fatty acids, butyrate, vitamin D and cortisol for a more accurate view of metabolic status.
Intestinal, oral and extended microbiome analyses including non-standard sampling according to symptoms.
Klotho protein and NAD+/NADH ratio as markers of vitality, cellular energy and healthy ageing.
Protein markers of inflammation, neurological damage and multiplex analysis of up to 80 markers in one test.
A section prepared for laboratory and clinical expansion of specialized genetic services.
Microbiome and dry blood spot diagnostics are designed to be simple for the client and robust for the laboratory.
A home collection kit is dispatched directly to the client.
Self-collection at home: stool, interdental plaque, saliva, buccal swab or dry blood spot depending on the test.
The sealed sample is returned to the laboratory by post.
A clear digital report is delivered with interpretation and reference ranges.
Point-of-care testing brings molecular diagnostic capability directly to the clinical setting — the dental chair, consultation room or GP practice.
Sample collection, external logistics and results usually after several days. Treatment planning may move to a second appointment.
Automated analysis at the practice, results during the same appointment and immediate patient understanding.
These tests can be presented as standalone diagnostics, bundles or partner-clinic services.
Pharmacogenetic analysis of drug metabolism, efficacy and adverse reaction risk across key therapy areas.
Intestinal microbiome profiling: diversity, F/B ratio, probiotic bacteria, SCFA producers and pathogen screening.
Fatty acid profile with 26 fatty acids and five indices including omega-3 index and omega-6:omega-3 ratio.
We can prepare testing for individual clients, clinics, dentists, partner laboratories and research projects.
